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Abstract
From a physiological standpoint, the lung volumes are either dynamic or static. Both subclasses are measured at
different degrees of inspiration or expiration; however, dynamic lung volumes are characteristically dependent on
the rate of air flow. The static lung volumes/capacities are further subdivided into four standard volumes (tidal,
inspiratory reserve, expiratory reserve, and residual volumes) and four standard capacities (inspiratory, functional
residual, vital and total lung capacities). The dynamic lung volumes are mostly derived from vital capacity. While
dynamic lung volumes are essential for diagnosis and follow up of obstructive lung diseases, static lung volumes
are equally important for evaluation of obstructive as well as restrictive ventilatory defects. This review intends to
update the reader with the physiological basis, clinical significance and interpretative approaches of the standard
static lung volumes and capacities.
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Background
Four standard lung volumes, namely, tidal (TV), inspiratory
reserve (IRV), expiratory reserve (ERV), and residual vol-
umes (RV) are described in the literature. Alternatively, the
standard lung capacities are inspiratory (IC), functional
residual (FRC), vital (VC) and total lung capacities (TLC).
Figure 1 gives a schematic summary of the standard lung
volumes and capacities [1–3]. RV constitutes part of FRC as
well as TLC and, therefore, these capacities are impossible
to measure through simple spirometers. The procedures
used for measurement of RV, FRC and TLC are based on
radiological, plethysmographic or dilutional techniques (he-
lium dilution and nitrogen washout methods) [4]. However,
body plethysmography and dilutional techniques may
under-and overestimate lung volumes and capacities, re-
spectively [5]. For the details of the procedures, advantages,
disadvantages and recommendations for best practice of
these techniques, the reader can refer to the reports revised
and published by the joint committee of ATS/ERS [6].
The way how static lung volumes and capacities
change in different physiological/pathological conditions
depends on the understanding of the mechanics of
breathing and the physiological determinants of
pulmonary ventilation, which will be discussed in the
following paragraphs.
Mechanics of breathing
Towards the end of tidal expiration, the lungs tend to
recoil inward while the chest wall tends to recoil out-
wards. These two opposing forces lead to a negative
pressure within the potential space between the parietal
and visceral pleurae. The negative intrapleural pressure
(PPl) is one of the important factors that keep the
patency of small airways, which lack cartilaginous sup-
port. The rhythmic contraction of inspiratory muscles
causes cyclic changes in the dimensions of the thoracic
cage and consequently comparable cyclic fluctuation of
PPl.
During tidal inspiration, PPl drops from −5 to −8
cmH2O enforcing the intra-alveolar pressure (Palv) to
drop one cmH2O below atmospheric pressure (Patm),
Fig. 2a. As a result, air flows into the alveoli. The drop
of PPl also decreases the airways resistance by dilating
the small airways and thus enhancing the air flow fur-
ther. The sequence of events reverses during tidal expir-
ation. When inspiratory muscles relax, dimensions of
the thoracic cage decrease, PPl increases from −8 back to
−5 cmH2O and Palv increases one cmH2O above Patm.
As a result, air flows outside the alveoli following the
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pressure gradient, Fig. 2b. Tidal expiration is therefore a
passive process, which needs no further muscle contrac-
tion. During tidal breathing, whether inspiratory or ex-
piratory, intra-airways (Paw) pressure is always more
than PPl. This explains why small airways are always
opened, even at the end of tidal expiration.
If inspiration above the tidal limit is required, accessory
muscles of inspiration must be activated. Thoracic cage
expands more leading to higher drop in PPl and Palv com-
pared with tidal inspiration, which explains why more air
is delivered to the alveoli compared with tidal inspiration.
Alternatively, expiration below the tidal level is an active
process that requires contraction of expiratory muscles.
During forceful expiration, the thoracic cage is com-
pressed to the maximum. Both PPl and Palv rise above
Patm; however, Palv remains more than PPl due to the effect
of elastic recoil pressure (Pel) of the alveolar wall. As dem-
onstrated in Fig. 3c, Paw decreases from the area next to
the alveoli upwards. This gradual drop in Paw is secondary
to simultaneous increase in the airways resistance towards
Fig. 1 Standard lung volumes and capacities from a spirometer trace. The solid black and gray arrows indicate lung volumes and capacities respectively
Fig. 2 Intrapleural and alveolar pressures towards the end of inspiration (a), expiration (b), and forceful expiration (c). The dotted line indicates
the change in thoracic dimensions during a, b and c compared with the previous phase of the respiratory cycle
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the trachea. Taking into consideration the relatively con-
stant PPl around the lung, each small airway can be subdi-
vided into three segments (Fig. 2c):
 An inflated segment, where PPl is lower than Paw.
 An equal pressure point, where PPl is equal to Paw.
 An airflow limiting segment, where PPl is higher
than Paw.
Development of airflow limiting segments occurs in
small airways that lack cartilaginous support and ex-
plains why the lungs cannot be empty completely. What
limits airflow upon forceful expiration was previously
explained by development of choke points i.e. the points
where local flow velocity equalizes the local speed of
pressure wave propagation (wave speed theory) [7, 8].
This is akin to a waterfall in which height and flow up-
stream the river are unlikely to affect the speed of the
free falling water; nevertheless, if waterfall is broader, an
extra water will be displaced. It is important to note that
upon forced expiration, the increase in Palv is accompan-
ied by gas compression within the lung. This will result
in reduction of both lung volume and Pel. The decrease
in Pel in turn attenuates the driving as well as the dis-
tending pressures at the choke points. This explains why
the actual volume of forcefully expired air is always less
than that measured with body plethysmograph. Based
on the preceding narrative, it is easy to interpret why
FEV1 measured with spirometer (FEV1-Sp) is typically
less than that measured with body plethysmograph
(FEV1-Pl) by an amount equal to thoracic gas compres-
sion volume (TGCV) [9–11].
Expiration after development of airflow limiting segments
is effort independent. What remains in the lungs when
small airways start to close is called the closing capacity
(CC) [12, 13]. Alternatively, RV remains in the lung when
all small airways are closed. The volume of air expired
between CC and RV is called the closing volume (CV).
It is evident from the above description that pulmon-
ary ventilation depends on the airways resistance offered
to the airflow and expansibility (compliance) of the lungs
and the thoracic cage. These two major determinants of
pulmonary ventilation are crucial for understanding the
pattern of change in static lung volume in different types
of lung diseases.
1. Airways resistance
The tracheobronchial tree undergoes successive di-
chotomizations, where the airways become narrower but
more distensible as we proceed downward. It is, there-
fore, difficult to apply simple laws of physics that govern
fluid flow across single, non-branched, non-distensible
tube system to evaluate respiratory airways resistance.
For example, the lowest airways resistance resides on
smallest bronchioles but not large airways. Because
bronchioles are arranged in parallel, their resistances de-
pend on the total cross sectional area of all bronchioles
rather than the radius of a single bronchiole.
Airways resistance is inversely proportional to the lung
volume. PPl decreases significantly upon inspiration,
which enhances distension of airways especially small
bronchioles. At higher lung volumes, attachments from
the alveolar walls pull small airways apart and hence
Fig. 3 Static PVC of the lungs and chest wall. The lung and chest wall curve was plotted by the addition of the individual lung and chest wall curves
Lutfi Multidisciplinary Respiratory Medicine  (2017) 12:3 Page 3 of 12
enhance the effect of PPl on decreasing airways resistance.
In contrast, airways resistance increases significantly dur-
ing forceful expiration due to formation of flow limiting
segments.
2. Compliance of the lung and the chest wall
Compliance is a physical term used to predict the
change in volume per unit change in the transmural
pressure (PT) i.e. the pressure difference across two sides
of a wall. From physiological perspective, the PT for the
lungs (trans-pulmonary pressure), chest wall (trans-chest
wall pressure) and respiratory system (trans-respiratory
pressure) are calculated by subtracting Palv – PPl, PPl –
Patm and Palv – Patm, respectively. According to physics,
if PT is equal to zero then the system is resting i.e.
neither inflating nor deflating.
Like lung volumes, the lung compliance can be measured
under static and dynamic conditions. Figure 3 shows the
static pressure volume curves (PVC) of the lungs and the
chest wall. The entire lung PVC in Fig. 3 falls within the
positive limb of Paw, suggesting the tendency of the lungs
to collapse at any degree of pulmonary inflation. The lungs
are never rested within the chest cage i.e. trans-pulmonary
pressure never reaches zero. If removed outside the body
then trans-pulmonary pressure can reach zero; however,
the lung will not be empty completely, Fig. 3.
In comparison, chest wall tends to recoil outward as
far as the lung is filled with 80% of TLC or less. At lung
volumes more than 80% of TLC, the chest wall recoils
inward, Fig. 3.
The lung–chest wall system is rested when Palv is
equal Patm and the lungs are filled with FRC. At this
point the inward recoil tendency of the lungs is equal to
the outward recoil tendency of the chest wall, Fig. 3.
The PVC of the lungs can also be recorded during
breathing to evaluate dynamic lung compliance. It is evi-
dent from Fig. 4a that dynamic PVC for inspiration and
expiration are separate and do not follow the same path-
way. This phenomenon is known as hysteresis and can
be explained by the variations of surface tension at
alveolar air-fluid interface during inspiration and expir-
ation. Pulmonary surfactant is a natural substance that
reduces surface tension of the fluid layer lining the
alveoli. During inspiration, alveolar surface tension is
likely to increase because pulmonary surfactant spreads
over a wider alveolar surface. The reverse occurs during
expiration, where pulmonary surfactant condenses in a
smaller alveolar surface. Hysteresis can also be explained
by progressive opening “recruitment” and closure “dere-
cruitment” of small airways and alveoli during inspir-
ation and expiration respectively.
The work of breathing is usually estimated by the area
under the dynamic PVC of the lungs (Fig. 4b). During
inspiration, the work needed to overcome elastic forces
of the chest wall, lungs parenchyma and alveolar sur-
face tension is called elastic work of breathing. In
addition, a resistive work is needed during inspiration
to overcome tissue and airways resistance. In contrast
to inspiration, only resistive work of breathing is re-
quired during expiration. Under physiological condition
the work needed for inspiration is more than that
needed for expiration. The energy stored in the elastic
lung structures during inspiration is partly consumed
as expiratory resistive work and partly dissipated as
heat (Fig. 4b).
Physiologically, the diseases that affect the respiratory
system are characterized by restrictive, obstructive or
combined pattern of ventilatory defects [14, 15]. Re-
strictive lung diseases (RLD) are associated with de-
creased compliance of the lungs, chest wall or both. This
results in rightward shift of static PVC of the lungs,
chest wall or both [15]. It is evident from Fig. 5 (a and
b) that decreased compliance of the lungs increases PPl
needed for tidal inspiration, yet tidal volume is below
the expected average. In RLD, the rightward shift of dy-
namic lung compliance curves increases the elastic work
of breathing required for inspiration, which is usually
compensated by rapid shallow breathing [16]. Causes of
RLD may be intrinsic or extrinsic to the lung paren-
chyma. Examples of intrinsic causes are interstitial lung
diseases, pneumonia and surfactant deficiency e.g. acute
respiratory distress syndrome. Alternatively, respiratory
muscles weakness, chest deformities, cardiomegaly, he-
mothorax, pneumothorax, empyema, pleural effusion or
thickening are examples of extrinsic causes.
In obstructive lung diseases (OLD), the pulmonary
compliance is normal or increased especially if emphyse-
matous lung changes co-exist. No extra-negative PPl is
needed as dynamic lung compliance curves are either
not displaced or shifted leftward if emphysematous lung
changes developed (Fig. 5c). The main defect in OLD is
increased airways resistance, especially during expiration.
Normally, expiration is a passive process as the energy
needed to overcome expiratory resistive work of breathing
is stored in the elastic fibers of the lung during inspiration.
It is evident from Fig. 5c that expiration is not completely
passive if OLD exists as an extra-work is needed during
expiration, which is usually performed with the aid of ex-
piratory muscles. Famous examples of obstructive pul-
monary diseases include bronchial asthma, emphysema,
chronic bronchitis and bronchiectasis.
Physiological determinant of the static lung
volumes and capacities
Age
The lung volumes increase steadily from birth to adult-
hood. The lungs mature at the age of 20–25 years, yet
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only minimal changes occur in the lung volumes over
the following 10 years [17]. After 35 years, aging is asso-
ciated with gradual changes in the lung volumes and
other pulmonary functions [18]. These changes include
enhanced static lung compliance due to diminished al-
veolar elastic recoil and depressed chest wall compliance
due to stiffening and increased outward recoil of the
thoracic cage [19, 20]. As a result of these changes in
the lung and chest wall compliances, the inward recoil
of the lung balances the outward recoil of the chest at
higher FRC as age progress [12, 13]. These variations in
lung and chest wall compliances act synergistically to
Fig. 5 Work of breathing in normal subjects (a) and patients with RLD (b) and OLD (c)
Fig. 4 a Dynamic PVC of the lungs. b Work of breathing
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cause early closure of small airways upon forced expir-
ation and hence explain increased RV in elder people
[19]. As shown in Fig. 6, TLC corrected for age remains
almost constant throughout life. However, gradual in-
crease in FRC and RV with age results in simultaneous
decrease in IC and VC, respectively [17]. It is also appar-
ent from Fig. 6 that the increase in CC when age
advances is more compared with FRC. This results in a
reduction of the difference between these two capacities
i.e. D (FRC ─ CC) as age progress. In the sitting pos-
ition, CC is likely to exceed FRC at an age of 75 years or
more [12] (Fig. 6), but much earlier in the supine pos-
ition (≈44 years) [13].
Gender
Standard morphometric methods confirmed that males
had larger lung size, more respiratory bronchioles and
wider airways diameters compared with females with the
same age and stature [21, 22]. These anatomical lung
differences between males and females explain the gen-
der variations in static lung volumes and capacities.
Males tend to have larger anthropometric measurements
and are, therefore, more likely to have increased static
lung volumes and capacities [23].
Anthropometric measurements
Tall stature is typically associated with higher static lung
volumes and capacities [24]. Increased body weight is as-
sociated with lower lung volumes in obese subjects [25].
Central obesity preferentially depresses chest wall com-
pliance leading to marked decrease in FRC and ERV
[26]. Waist-to-hip ratio could be a better predictor for
fat distribution than BMI [27]. However, the effects of
obesity on the highest (TLC) and lowest (RV) lung vol-
umes are modest [28]. In athletes, repeated muscular ex-
ercise increases muscle mass and consequently body
weight. In such condition, the static lung volumes and
capacities are expected to increase with weight [29–32].
Increased total body fat content, therefore, seems better
than high BMI as an indicator of obesity as well as pre-
dictor for decreased static lung volumes and capacities
[33].
Ethnicity
Previous studies demonstrated ethnic differences in the
lung volumes/capacities [34, 35]. Such variations were
largely attributed to anthropometric differences between
different ethnic groups. For example, white Americans
of European descent have larger trunk/leg ratio, and
consequently higher lung volumes, compared with black
Americans of African descent [36]. Other studies failed
to justify ethnic differences in lung volumes by the varia-
tions in chest contours and suggest differences in in-
spiratory muscle strength and/or lung compliance as
alternative explanation(s) [37]. Recently, GLI (Global
Lung Initiative) offered spirometric prediction equations,
that also considered ethnic differences, to be used
worldwide [38].
Other factors
Although age, gender, weight, height and ethnicity are
the main physiological determinants of the static lung
volumes/capacities, other factors should be considered
while interpreting results of spirometry.
Fig. 6 Changes in static lung volume and capacities with age
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Lung volumes correlate well with the level of physical
activity [39], regular exercise, especially swimming and
endurance training [32]. Alternatively, ascending to high
altitude may decrease lung volumes probably due to in-
creased pulmonary blood flow, pulmonary edema or pre-
mature small airways closure [40]. Alterations in lung
volumes associated with high altitude are usually tem-
poral and resolve after returning to the sea level [41].
The position of the subject is important while measur-
ing lung volumes and capacities [42]. Compared with
the standing position, the effect of gravity on abdominal
viscera is less at sitting position and least if lying supine
[43]. The supine position, therefore, compromises dia-
phragmatic movement and chest wall recoil during
breathing. FRC and ERV are higher upon standing com-
pared with sitting and supine positions [44]. Increased
intra-abdominal pressure during pregnancy also causes
decreased FRC and ERV [45].
Interpretation of static lung volumes and
capacities
The quality and accuracy of the test(s) used for estimation
of the lung volumes/capacities should be ensured before
interpretation [46]. The measurement of the lung volumes
is not an easy task and requires cooperative patients and
qualified technicians. Personnel in the pulmonary labora-
tory must be able to judge precisely test acceptability and
reproducibility criteria for the different techniques used
for estimation of the lung volumes/capacities [46]. Special
attention should be given to the accuracy of the method
used for estimation of the static lung volumes and capaci-
ties. Plethysmography was claimed to overestimate while
dilutional techniques may underestimate the true mea-
surements of the lung volumes and capacities [5].
The normal lung volumes and capacities can be pre-
dicted based on gender, age, weight, height and ethnicity
of the subject [47]. Although authorized spirometric ref-
erence values are available for most populations, normal
ranges of lung volumes and capacities were not estab-
lished in others yet. Static lung volumes and capacities
are frequently expressed as a percent of the predicted
value, where 80% and 120% are considered as the lower
(LLN) and upper (ULN) limits of normal. However, the
use of these cut-off points may be misleading in charac-
terizing ventilatory defects in some pulmonary diseases
if only simple spirometry is performed [48, 49].
Patterns of changes of static lung volumes and
capacities in pulmonary diseases
Restrictive lung diseases
Diseases associated with diminished pulmonary compli-
ance interfere with lung expansion and ultimately reduce
static lung volumes/capacities, Fig. 7. According to ATS/
ERS, restrictive ventilatory defect is ideally confirmed by
a reduction in TLC below the 5th percentile of the pre-
dicted value, and a normal FEV1/VC [46], though most
pulmonary laboratories use VC instead because it consti-
tutes most of the TLC [50, 51]. The use of VC as a surro-
gate for TLC in diagnosis of RLD assumes a proportional
decrease in RV and TLC so that their ratio remains con-
stant [46, 52]. Simultaneous increase of RV with VC reduc-
tion is indicative of obstructive lung disease because of
small airway closure or expiratory flow limitation [53].
Therefore, decreased VC readings are better interpreted in
conjunction with other clinical and spirometric indicators
of OLD, especially if measurements of RV and TLC are not
available [54]. According to Aaron et al., the chances of re-
strictive ventilatory defect are 2.4% and 58% in those with
normal and low VC readings, respectively [55]. These find-
ings suggest that normal VC may be effective in exclusion,
but not confirmation, of RLD. This hypothesis is further
supported by Vandevoorde et al., who concluded that RLD
can be ruled out if FVC is more than 100% of predicted in
males or greater than 85% of predicted in females [56].
If thoracic cage expansion is restricted, rightward dis-
placement of the chest wall static PVC takes place. This
readjusts the point where the inward recoil of the lung
equalizes the outward recoil of the chest wall at a lower
FRC level. In cases with severe central obesity, decreased
chest wall compliance reduces FRC and ERV [57]. Ac-
cording to Jones et al., FRC and ERV at a body mass index
(BMI) of 30 kg/m2 were about 75% and 47% of the re-
spective measurements for subjects with BMI of 20 kg/m2
[26]. The same study failed to demonstrate a significant ef-
fect of high BMI on RV/TLC ratio, which indicates pro-
portional reduction in RV and TLC in overweight and
obese subjects. Marked reduction of FRC and ERV in such
cases may induce premature formation of flow limiting
segments during quiet breathing, especially in the lower
regions of the lungs [57]. This implication is further sup-
ported by the studies that confirm an inverse relationship
between FRC and airway resistance in obese patients [58,
59]. Furthermore, temporal variability of ventilation het-
erogeneities increases in obesity when FRC falls approxi-
mately below 65% of predicted or ERV below 0.6 l,
promoting ventilation perfusion inhomogeneity and even-
tually hypoxemia [60].
Obstructive lung diseases
ATS/ERS defined obstructive ventilatory defect as “dis-
proportionate reduction of maximal airflow from the
lung in relation to the maximal volume (i.e. VC) that
can be displaced from the lung” [46]. Obstructive venti-
latory defect is ideally confirmed by FEV1/VC ratio
below the 5th percentile of the predicted value [46].
VC can be measured while doing slow (SIVC) or
forceful (FIVC) inspiration starting from RV up to the
level of TLC [61, 62]. Likewise, VC can be estimated
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while doing slow (SEVC) or forceful (FEVC) expiration
starting from TLC up to the level of RV [62, 63]. Taking
into consideration the variations in airways resistance
between inspiration and expiration, it is easy to conclude
that different types of VC are not equal. The differences
between the four types of VC are minimal in those with
no ventilatory defect [61]. In patients with OLD, FIVC >
SIVC > SEVC > FEVC [50, 63]. FEVC (commonly abbre-
viated as FVC) is, therefore, the most affected type of
VC in cases with severe obstructive lung disease [63].
In OLD, formation of flow limiting segments occurs
early due to narrowing of airways. Premature closure of
small airways in OLD results in increased RV. In such
conditions, RV may increase at the expense of VC so that
TLC remains unchanged [53]. Alternatively, RV may in-
crease while VC remains almost unchanged leading to
higher TLC values [64]. In both scenarios, RV/TLC ratio
is likely to increase irrespective of the changes in the VC,
a fact that explains the superiority RV/TLC over TLC in
evaluation of OLD [65].
Similar to the RV and VC changes occurring in patients
with OLD, FRC may increase at the expense of IC so that
TLC remains unchanged [4]. IC can directly be measured
by spirometry, which is advantageous in places where there
are no facilities to measure RV and TLC. There are accu-
mulating evidences that indices derived from IC are helpful
to assess severity, prognosis and response to treatment of
many OLD [66–69]. According to Yetkin and Gunen, IC is
more efficient than FEV1 is assessing severity of COPD dur-
ing acute exacerbation [68]. In another study, COPD
patients with IC/TLC ratio < 25% are more likely to have
unscheduled doctor visits due to exacerbations or need of
carefully monitored treatment [69]. This fact is further sup-
ported by the finding of French et al., where IC/TLC ≤ 25%
was identified as significant predictor of death in patients
with emphysematous COPD [67].
It is evident from the above reports that air trapping in
obstructive ventilatory defects correlates positively with
RV, FRC, TLC and RV/TLC, but negatively with VC, IC
and IC/TLC. As described earlier, FIVC > SIVC > SEVC >
FEVC in patients with OLD [50, 63]. Accordingly, lung
hyperinflation can also be evaluated by assessing the dif-
ference between FIVC and FEVC [62, 63, 70, 71]. Larger
difference between FIVC and FEVC had been validated
not only as an efficient index of severity of airflow limita-
tion, but also as powerful predictor of exercise tolerance
in patients with COPD [62, 71]. Likewise, lung hyperinfla-
tion secondary to air trapping can be estimated by calcu-
lating the difference between lung volumes measured by
plethysmography and dilutional techniques. This assump-
tion was validated by Tantucci et al. when they evaluated
FRC in asthmatic patient by plethysmography (FRCpl) and
helium dilution method (FRCHe) following methacholine
challenge test [72]. The results confirmed that comparing
FRCpl with FRCHe was helpful in identifying asthmatic pa-
tients at risk of tidal airway closure induced by methacho-
line. In addition, Tantucci et al. demonstrated significant
correlation between (FRCpl ─ FRCHe) and the unventil-
ated lung volume following provocation of bronchocon-
striction [72]. Typical changes in the static lung volumes
and capacities in OLD are summarized in Fig. 7.
It is important to note that FEV1 should be interpreted
with caution when measured with spirometers (FEV1-Sp) ra-
ther than plethysmography (FEV1-Pl). As explaineed earlier,
FEV1-Sp, but not FEV1-Pl, is biased by TGCV [9–11]. In a
recent study involving asthmatic patients during methacho-
line challenge, FEV1-Sp overestimated bronchoconstrictor
response in those with larger lung volume [73]. FEV1-Sp also
overestimated bronchodilator response following adminis-
tration of salbutamol to the same patients. In another study,
FEV1-Sp and FEV1-Pl were simultaneously measured in 47
and 51 subjects with dominant emphysema and dominant
Fig. 7 Typical changes in the static lung volumes and capacities in RLD and OLD
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chronic bronchitis, respectively [74]. The results confirmed
larger lung volumes and lower FEV1-Sp in emphysematous
patients compared with those with dominant chronic bron-
chitis. When FEV1-Pl was used instead of FEV1-Sp, the dis-
ease severity was less in classes with dominant emphysema
than those with dominant chronic bronchitis. The study
concluded that FEV1-Sp was biased by TGCV more in
patients with dominant emphysema because their TLCs
were larger.
Mixed obstructive and restrictive lung diseases
Decreased TLC in patients with spirometric evidence of
airways obstruction e.g. RV above ULN or FEV1% below
LLN is suggestive of mixed obstructive-restrictive lung
diseases (MORLD). In MORLD, premature formation of
flow limiting segments and diminished pulmonary com-
pliance synergistically decrease FVC. The reduction in
FVC sometimes exceeds that occurs in FEV1 and conse-
quently results in relatively higher FEV1% [75]. This fact
explains the findings of Balfe et al. study, which compared
grading of airway obstruction based FEV1 (American
Thoracic Society (ATS) recommendation) and FEV1% (In-
termountain Thoracic Society (ITS) recommendation).
According to Balfe et al. results, ATS recommendation
graded 90% of 147 MORLD patients as having severe ob-
struction while ITS recommendation graded only 3% with
the same degree of obstruction [76]. An additional evi-
dence was given by another study that demonstrated an
inverse correlation between FEV1% and RV/TLC in pa-
tients with MORLD [77]. Accordingly, adjustment of
FEV1% for the reduction in TLC is likely to improve grad-
ing of the severity of obstruction in patients with MORLD.
This assumption was verified in a study evaluating 199 pa-
tients with MORLD, where FEV1%/TLC was used for ad-
justment for the degree of restriction [78]. Based on ATS/
ERS grading, 76% and 11% of MORLD patients were clas-
sified as having severe and mild-to-moderate obstruction,
respectively. In comparison, the adjusted FEV1% (FEV1%/
TLC) classified 33% and 44% of the same patients as hav-
ing severe and mild-to-moderate obstruction. The study
concluded that subdividing FEV1% by TLC resulted in an
appropriate severity classification of obstruction when
restriction coexists [78].
Non-specific pattern of changes in lung
volumes and capacities
The term non-specific pattern (NSP) is used to describe
coexistence of low FEV1 and FVC with normal TLC and
FEV1% [46, 79]. Although lower values of both FEV1
and FVC are associated with obstructive as well as
restrictive ventilatory defect, the other components of
NSP (i.e. normal TLC and FEV1%) minimize the possi-
bility of these conditions. Hypothetically, if RV increases
while TLC remains unchanged, VC and consequently
FEV1 are expected to decrease below the normal limits.
NSP may, therefore, reflect an obstructive impairment of
small airways, where RV expands at the expense of VC
so that TLC remains unaffected [53, 79]. However, NSP
was also demonstrated in patients with restrictive venti-
latory defects [80]. In a previous study, in depth evalu-
ation of a random sample of patients with the NSP
confirmed OLD and RLD as a possible cause in 68% and
32% of the examined subjects, respectively [80]. In an-
other study, NSP persisted in 64% of 1,284 patients after
3 years follow up. Nonetheless, the NSP changed to
RLD, OLD, MORLD and normal patterns in 16%, 15%,
2% and 3% of the studied patients, respectively [81]. Pos-
sible explanation for NSP in patients with restrictive
ventilatory defects remains for further investigations and
researches.
Conclusions
Physiological factors that influence lung volumes/capaci-
ties include age, gender, weight, height and ethnicity,
physical activity, altitude and others, which should be
considered while interpreting results of spirometry. Like-
wise, the quality and accuracy of the test(s) used for esti-
mation of the lung volumes/capacities should be
considered before interpretation.
RLDs are ideally confirmed by low TLC, though most
pulmonary laboratories use VC instead. VC instead of
TLC may be effective in exclusion, but not confirmation,
of RLD. Simultaneous increase in RV with VC reduction
is indicative of obstructive lung disease. Therefore, de-
creased VC readings are better interpreted in conjunc-
tion with other clinical and spirometric indicators of
OLD. In RLD like central obesity, decreased chest wall
compliance reduces FRC and ERV, which may induce
premature formation of flow limiting segments during
quiet breathing.
Premature closure of small airways in OLDs results in
increased RV. In such conditions, RV may increase at
the expense of VC so that TLC remains unchanged. Al-
ternatively, RV may increase while VC remains almost
unchanged leading to higher TLC values. In both scenar-
ios, RV/TLC ratio is likely to increase irrespective of the
changes in the VC, a fact that explains the superiority
RV/TLC over TLC in evaluation of OLD. Similarly, FRC
may increase at the expense of IC so that TLC remains
unchanged.
Decreased TLC in patients with spirometric evidence
of airways obstruction is suggestive of MORLD. In such
conditions, the reduction in FVC exceeds that occurs in
FEV1 and consequently results in relatively higher
FEV1%. The term NSP is used to describe coexistence of
low FEV1 and FVC with normal TLC and FEV1%. NSP
may reflect an obstructive impairment of small airways,
where RV expands at the expense of VC so that TLC
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remains unaffected. NSP was also demonstrated in pa-
tients with restrictive ventilatory defects, which needs
further investigations and researches.
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